JP4331227B2 - 抗グリピカン３抗体 - Google Patents

抗グリピカン３抗体 Download PDF

Info

Publication number
JP4331227B2
JP4331227B2 JP2007134209A JP2007134209A JP4331227B2 JP 4331227 B2 JP4331227 B2 JP 4331227B2 JP 2007134209 A JP2007134209 A JP 2007134209A JP 2007134209 A JP2007134209 A JP 2007134209A JP 4331227 B2 JP4331227 B2 JP 4331227B2
Authority
JP
Japan
Prior art keywords
seq
antibody
amino acid
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007134209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007300927A5 (https=
JP2007300927A (ja
Inventor
清孝 中野
吉野　　武
淳一 根津
浩行 角田
智之 井川
博子 小西
めぐみ 田中
泉 周郷
重人 川合
敬弘 石黒
恭子 木下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP2007134209A priority Critical patent/JP4331227B2/ja
Publication of JP2007300927A publication Critical patent/JP2007300927A/ja
Publication of JP2007300927A5 publication Critical patent/JP2007300927A5/ja
Application granted granted Critical
Publication of JP4331227B2 publication Critical patent/JP4331227B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2007134209A 2004-07-09 2007-05-21 抗グリピカン３抗体 Expired - Fee Related JP4331227B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007134209A JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004203637 2004-07-09
JP2007134209A JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006524550A Division JP4011100B2 (ja) 2004-07-09 2005-07-08 抗グリピカン３抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009113159A Division JP2009232848A (ja) 2004-07-09 2009-05-08 抗グリピカン３抗体

Publications (3)

Publication Number Publication Date
JP2007300927A JP2007300927A (ja) 2007-11-22
JP2007300927A5 JP2007300927A5 (https=) 2008-08-21
JP4331227B2 true JP4331227B2 (ja) 2009-09-16

Family

ID=38835421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007134209A Expired - Fee Related JP4331227B2 (ja) 2004-07-09 2007-05-21 抗グリピカン３抗体

Country Status (1)

Country Link
JP (1) JP4331227B2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009000647A1 (es) * 2008-04-04 2010-06-04 Chugai Pharmaceutical Co Ltd Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
TWI693073B (zh) * 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
JP6827319B2 (ja) 2014-05-08 2021-02-10 中外製薬株式会社 Ｇｐｃ３標的治療剤療法が有効である患者に投与されるｇｐｃ３標的治療剤
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
JP7096667B2 (ja) 2015-07-01 2022-07-06 中外製薬株式会社 Ｇｐｃ３標的治療剤が有効である患者に投与されるｇｐｃ３標的治療剤
CN114080452B (zh) * 2019-06-27 2025-06-03 优特力克斯有限公司 具有4-1bb共刺激结构域的嵌合抗原受体

Also Published As

Publication number Publication date
JP2007300927A (ja) 2007-11-22

Similar Documents

Publication Publication Date Title
JP5715603B2 (ja) 抗グリピカン３抗体
JP4794457B2 (ja) 糖鎖改変抗グリピカン３抗体
US8546546B2 (en) Anti-Muc 17 antibody
JPWO2004022754A1 (ja) ＭＲＬ／ｌｐｒマウスを用いた抗体の作製
JP4331227B2 (ja) 抗グリピカン３抗体
JP4794303B2 (ja) 固形腫瘍治療剤
HK40032021A (en) Anti-glypican 3 antibody
HK1085410A (en) Anti-glypican 3 antibody
HK1227411A1 (en) Anti-glypican 3 antibody
HK1172034A (en) Anti-glypican 3 antibody
HK1092161B (en) Anti-glypican 3 antibody

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080707

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090508

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090602

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090617

R150 Certificate of patent or registration of utility model

Ref document number: 4331227

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120626

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120626

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120626

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130626

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130626

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees